Cyproterone acetate--indications restricted because of hepatotoxicity and possible carcinogenicity.
D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000627:therapeutic use*; D004348:Drug Labeling; D006801:Humans; D013188:Sri Lanka
D017373:Cyproterone Acetate